The equity capital markets have experienced an uptick in transactions this year, despite a "soft open" in Initial Public Offerings (IPOs), according to Goldman Sachs (NYSE:GS)' Lizzie Reed. High-profile IPOs including Arm Holdings (NASDAQ:ARM), Klaviyo, and Instacart have collectively raised $6 billion, even though they were met with share price drops.
Barclays (LON:BARC)' Robert Stowe characterized the current state of the market as "rebuilding," while Citigroup’s Suneel Hargunani expects a gradual re-opening of the market. Amid these developments, there have been successful debuts from companies such as Schott Pharma, ThyssenKrupp Nucera, and Hidrolectrica.
Cornerstone investments in market leaders have been highlighted by Deutsche Bank (ETR:DBKGn)'s Stephane Gruffat. Notably, Arm has received backing from tech giants Nvidia (NASDAQ:NVDA) and Apple (NASDAQ:AAPL), while Schott Pharma has secured support from Qatar Investment Authority.
Thoma Bravo's Ross Devor and Mizuho Americas' Josh Weismer emphasized the importance of profitability in determining valuation and market performance. The role of SoftBank (TYO:9984) as an investor in Arm was also mentioned, underscoring the ongoing interest of major players in these market leaders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.